797 related articles for article (PubMed ID: 17828282)
1. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
3. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
4. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition: mechanism of action.
DeMartino GN
J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
[TBL] [Abstract][Full Text] [Related]
7. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition as a therapeutic strategy for hematologic malignancies.
Mitsiades CS; Mitsiades N; Hideshima T; Richardson PG; Anderson KC
Expert Rev Anticancer Ther; 2005 Jun; 5(3):465-76. PubMed ID: 16001954
[TBL] [Abstract][Full Text] [Related]
9. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
Chada S; Sutton RB; Ekmekcioglu S; Ellerhorst J; Mumm JB; Leitner WW; Yang HY; Sahin AA; Hunt KK; Fuson KL; Poìndexter N; Roth JA; Ramesh R; Grimm EA; Mhashilkar AM
Int Immunopharmacol; 2004 May; 4(5):649-67. PubMed ID: 15120650
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.
Zaman F; Menendez-Benito V; Eriksson E; Chagin AS; Takigawa M; Fadeel B; Dantuma NP; Chrysis D; Sävendahl L
Cancer Res; 2007 Oct; 67(20):10078-86. PubMed ID: 17942942
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms.
Kawabe S; Nishikawa T; Munshi A; Roth JA; Chada S; Meyn RE
Mol Ther; 2002 Nov; 6(5):637-44. PubMed ID: 12409262
[TBL] [Abstract][Full Text] [Related]
12. Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer.
Marx C; Yau C; Banwait S; Zhou Y; Scott GK; Hann B; Park JW; Benz CC
Mol Pharmacol; 2007 Jun; 71(6):1525-34. PubMed ID: 17392524
[TBL] [Abstract][Full Text] [Related]
13. Critical role of lysine 123 in the ubiquitin-mediated degradation of MDA-7/IL-24.
Tian H; Li L; Zhang B; Di J; Chen F; Li H; Liu J; Pei D; Zheng J
J Interferon Cytokine Res; 2012 Dec; 32(12):575-82. PubMed ID: 23078624
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
Saito Y; Miyahara R; Gopalan B; Litvak A; Inoue S; Shanker M; Branch CD; Mhashilkar AM; Roth JA; Chada S; Ramesh R
Cancer Gene Ther; 2005 Mar; 12(3):238-47. PubMed ID: 15578066
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
Yerlikaya A; Erin N
Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
[TBL] [Abstract][Full Text] [Related]
16. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway.
Chen ZY; Wang X; Zhou Y; Offner G; Tseng CC
Cancer Res; 2005 Nov; 65(22):10394-400. PubMed ID: 16288030
[TBL] [Abstract][Full Text] [Related]
17. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
Chada S; Mhashilkar AM; Ramesh R; Mumm JB; Sutton RB; Bocangel D; Zheng M; Grimm EA; Ekmekcioglu S
Mol Ther; 2004 Dec; 10(6):1085-95. PubMed ID: 15564140
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.
Kesarwala AH; Samrakandi MM; Piwnica-Worms D
Cancer Res; 2009 Feb; 69(3):976-83. PubMed ID: 19176375
[TBL] [Abstract][Full Text] [Related]
19. Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells.
Carelli S; Di Giulio AM; Paratore S; Bosari S; Gorio A
J Cell Physiol; 2006 Aug; 208(2):354-62. PubMed ID: 16619240
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
Thorpe JA; Christian PA; Schwarze SR
Prostate; 2008 Feb; 68(2):200-9. PubMed ID: 18076022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
